| Dr Kristina Bell Mcclish, MD | |
|
1202 W Oak St, Greenville, MI 48838-2155 | |
| (616) 754-2944 | |
| (616) 754-2999 |
| Full Name | Dr Kristina Bell Mcclish |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 1202 W Oak St, Greenville, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659595452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301088159 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health United | 6305836487 | 52 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Mecosta County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386693471 PECOS PAC ID: 1951215540 Enrollment ID: O20031118000335 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Pennock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518186295 PECOS PAC ID: 4587551015 Enrollment ID: O20040301000595 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Newaygo County General Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750404927 PECOS PAC ID: 4880503051 Enrollment ID: O20040423001232 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Spectrum Health United |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457304495 PECOS PAC ID: 6305836487 Enrollment ID: O20040612000087 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Entity Name | Memorial Medical Center Of West Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972589489 PECOS PAC ID: 3678543659 Enrollment ID: O20071128000647 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristina Bell Mcclish, MD 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: (616) 486-6790 | Dr Kristina Bell Mcclish, MD 1202 W Oak St, Greenville, MI 48838-2155 Ph: (616) 754-2944 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).
Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.
› Verified 2 days ago
Ruth Ann Bruce, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1202 W Oak St, Greenville, MI 48838 Phone: 616-754-2944 Fax: 616-754-2999 | |
Miss Connie Januzelli, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1202 W Oak St, Greenville, MI 48838 Phone: 616-754-2944 | |
Dr. Andrea Sue Sterling, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1202 W Oak St, Ste 100, Greenville, MI 48838 Phone: 616-754-2944 | |
Yelena Pavlovna Davis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1202 W Oak St, Greenville, MI 48838 Phone: 616-754-2944 Fax: 616-754-2999 | |
Bennett S Walstatter, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1202 W Oak St, Greenville, MI 48838 Phone: 616-754-2944 Fax: 616-754-2999 | |
Lauren Michelle Beghtol, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1202 W Oak St, Greenville, MI 48838 Phone: 616-754-2944 |